Skip to main content
SpringerLink
Log in

Particularités du cancer du sein chez la personne âgée

  • Chapter
Le cancer du sein

Part of the book series: Oncologie pratique ((ONCOLPRAT))

Abstrait

En Europe et en Amérique du Nord, les femmes porteuses ďun cancer du sein sont âgées de plus de 65 ans dans 30% à plus de 50% des cas. Dans ďautres régions, comme ľAfrique ou ľAsie du Sud-Est, la population est dans ľensemble plus jeune, et les données épidémiologiques sont fragmentaires. Il y a moins de cas «âgés», mais il est difficile de savoir si le risque de développer un cancer du sein chez les femmes de plus de 65 ans est le même qu’en Europe, ou moindre. Nous savons que ľincidence est moindre dans ľensemble des pays en voie de développement, surtout dans les campagnes, alors que ľincidence augmente dans les populations des villes, se rapprochant peu à peu des taux européens. Bien que très nombreuses, ces patientes âgées ont été souvent exclues des études cliniques jusqu’à récemment. De nombreuses mauvaises raisons sont avancées pour expliquer cette situation, alors que nous savons qu’une femme «moyenne», âgée de 70 ans, a une espérance de vie de 15 ans et devrait donc pouvoir bénéficier de tous les traitements disponibles. À situation biologique tumorale égale, les femmes âgées ont en effet le même pronostic que les femmes plus jeunes. Par rapport aux femmes plus jeunes, elles présentent plus souvent des métastases au moment du diagnostic et décèdent plus souvent ďautres maladies que le cancer (1). Ces données sont illustrées par les résultats ďune observation de 2919 patientes âgées de plus de 65 ans, dans un collectif de 9228 patientes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Castiglione M, Gelber RD, Goldhirsch A (1990) Adjuvant systemic therapy for breast cancer in the elderly: competing causes of mortality. International Breast Cancer Study Group. J Clin Oncol 8: 519–26

    PubMed  CAS  Google Scholar 

  2. Clark GM (1992) The biology of breast cancer in older women. J Gerontol 47: 19–23

    PubMed  Google Scholar 

  3. Daidone MG, Coradini D, Martelli G, Veneroni S (2003) Primary breast cancer in elderly women: biological profile and relation with clinical outcome. Crit Rev Oncol Hematol 45: 313–25

    Article  PubMed  Google Scholar 

  4. Molino A, Giovannini M, Auriemma A et al. (2006) Pathological, biological and clinical characteristics, and surgical management of elderly women with breast cancer. Crit Rev Oncol Hematol 59: 226–33

    Article  PubMed  Google Scholar 

  5. Gennari R, Curigliano G, Rotmensz N et al. (2004) Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopausal patients. Cancer 101: 1302–10

    Article  PubMed  Google Scholar 

  6. Fracheboud J, Groenewoud JH, Boer R et al. (2006) Seventy-five years is an appropriate upper age limit for population-based mammography screening. Int J Cancer 118: 2020–5

    Article  PubMed  CAS  Google Scholar 

  7. Parvinen I, Helenius H, Pylkkanen L et al. (2006) Service screening mammography reduces breast cancer mortality among elderly women in Turku. J Med Screen 13: 34–40

    Article  PubMed  CAS  Google Scholar 

  8. Fish EB, Chapman JA, Link MA (1998) Competing causes of death for primary breast cancer. Ann Surg Oncol 5: 368–75

    Article  PubMed  CAS  Google Scholar 

  9. Extermann M, Aapro M (2000) Assessment of the older cancer patient. Hematol Oncol Clin North Am 14: 63–77

    Article  PubMed  CAS  Google Scholar 

  10. Repetto L, Fratino L, Audisio RA et al. (2006) Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 20: 494–502

    Article  Google Scholar 

  11. Extermann M, Aapro M, Bernabei R et al. (2005) Task Force on CGA of the International Society of Geriatric Oncology. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 55: 241–52

    Article  PubMed  Google Scholar 

  12. Gazet JC, Ford HT, Coombes RC et al. (1994) Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer. Eur J Surg Oncol 20: 207–14

    PubMed  CAS  Google Scholar 

  13. Robertson JF, Ellis IO, Elston CW, Blamey RW (1992) Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-up. Eur J Cancer 28A: 908–910

    Article  PubMed  CAS  Google Scholar 

  14. Bates T, Riley DL, Houghton J et al. (1991) Breast cancer in elderly women: a Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. The Elderly Breast Cancer Working Party. Br J Surg 78: 591–94

    Article  PubMed  CAS  Google Scholar 

  15. Mustacchi G, Ceccherini R, Pluchinotta A et al. (2002) Results of adjuvant treatment in breast cancer women aged more than 70: Italian cooperative group experience. Tumori 88 (Suppl 1): S83–5

    PubMed  Google Scholar 

  16. Dixon JM, Love CD, Bellamy CO et al. (2001) Letrozole as primary medical therapy for locally advanced and large operable breast cancer. Breast Cancer Res Treat 66: 191–9

    Article  PubMed  CAS  Google Scholar 

  17. Miller WR, Dixon JM (2002) Endocrine and clinical endpoints of exemestane as neoadjuvant therapy. Cancer Control 9: 9–15

    PubMed  Google Scholar 

  18. Eiermann W, Paepke S, Appfelstaedt J et al. (2001) Letrozole Neo-Adjuvant Breast Cancer Study Group. Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study. Ann Oncol 12: 1527–32

    Article  PubMed  CAS  Google Scholar 

  19. Hind D, Wyld L, Beverley CB, Reed MW (2006) Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus). Cochrane Database Syst Rev (1): CD004272

    Google Scholar 

  20. Wazer DE, Erban JK, Robert NJ et al. (1994) Breast conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection. Cancer 74: 878

    Article  PubMed  CAS  Google Scholar 

  21. Amsterdam E, Birkenfield S, Gilad A, Krispin M (1987) Surgery for carcinoma of the breast in women over 70 years of age. J Surg Oncol 35: 180

    Article  PubMed  CAS  Google Scholar 

  22. Svastics E, Sulyok Z, Besznyak I (1989) Treatment of breast cancer in women older than 70 years of age. J Surg Oncol 41: 19

    Article  PubMed  CAS  Google Scholar 

  23. Samain E, Schauvliège F, Marty J (2003) Anesthesia for breast cancer surgery in the elderly. Crit Rev Oncol Hematol 46: 115–20

    Article  PubMed  Google Scholar 

  24. Veronesi U, Marubini E, Mariani L, et al. (2001) Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 12: 997–1003

    Article  PubMed  CAS  Google Scholar 

  25. Kantorowitz DA, Poulter CA, Rubin P et al. (1989) Treatment of breast cancer with segmental mastectomy alone or segmental mastectomy plus radiation. Radiother Oncol 15: 141–50

    Article  PubMed  CAS  Google Scholar 

  26. Hughes KS, Schnaper LA, Berry D et al. (2004) Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351: 971–7

    Article  PubMed  CAS  Google Scholar 

  27. Truong PT, Bernstein V, Lesperance M et al. (2006) Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer. Am J Surg 191: 749–55

    Article  PubMed  Google Scholar 

  28. Smith BD, Gross CP, Smith GL et al. (2006) Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst 98: 681–90

    Article  PubMed  Google Scholar 

  29. Courdi A, Ortholan C, Hannoun-Levi JM et al. (2006) Long-term results of hypofractionated radiotherapy and hormonal therapy without surgery for breast cancer in elderly patients. Radiother Oncol 79: 156–61

    Article  PubMed  Google Scholar 

  30. Early Breast Cancer Trialists Callaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365: 1687–717

    Article  CAS  Google Scholar 

  31. Joensuu H, Ejlertsen B, Lonning PE, Rutqvist LE. Aromatase inhibitors in the treatment of early and advanced breast cancer. Acta Oncol 44: 23–31

    Google Scholar 

  32. Aapro M (2006) Improving bone health in patients with early breast cancer by adding bisphosphonates to letrozole: The Z-ZO-E-ZO-FAST program. Breast 15 (Suppl 1): 30–40

    Article  Google Scholar 

  33. Goldhirsch A, Glick JH, Gelber RD et al. (2005) Panel members. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 16: 1569–83

    Article  PubMed  CAS  Google Scholar 

  34. Ershler WB (2006) Capecitabine monotherapy: safe and effective treatment for metastatic breast cancer. Oncologist 11: 325–35

    Article  PubMed  CAS  Google Scholar 

  35. Biganzoli L, Coleman R, Minisini A et al. (2007) A joined analysis of two European Organization for the Research and Treatment of Cancer (EORTC) studies to evaluate the role of pegylated liposomal doxorubicin (Caelyxtrade mark) in the treatment of elderly patients with metastatic breast cancer. Crit Rev Oncol. Hematol 61: 84–9

    Article  PubMed  Google Scholar 

  36. Gebbia V, Puozzo C (2005) Oral versus intravenous vinorelbine: clinical safety profile. Expert Opin Drug Saf 4: 915–28

    Article  PubMed  CAS  Google Scholar 

  37. Dinota A, Bilancia D, Romano R, Manzione L (2005) Biweekly administration of gemcitabine and vinorelbine as first line therapy in elderly advanced breast cancer. Breast Cancer Res Treat 89: 1–3

    Article  PubMed  CAS  Google Scholar 

  38. Marrs J (2005) Osteoporosis in the oncology setting. Clin J Oncol Nurs 9: 261–3

    Article  PubMed  Google Scholar 

  39. Uebelhart B, Rizzoli R (2006) Osteoporosis treatment. Rev Med Suisse 2: 47–51

    PubMed  CAS  Google Scholar 

  40. Aapro MS, Cameron DA, Pettengell R et al. (2006) European Organisation for Research and Treatment of Cancer (EORTC) Granulocyte Colony-Stimulating Factor (G-CSF) Guidelines Working Party. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. Eur J Cancer 42: 2433–53

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut multidisciplinaire ďoncologie, Clinique de Genolier, 1 route du Muids, CH-1272, Genolier, Suisse

    Matti S. Aapro

Authors
  1. Matti S. Aapro
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag France

About this chapter

Cite this chapter

Aapro, M.S. (2007). Particularités du cancer du sein chez la personne âgée. In: Le cancer du sein. Oncologie pratique. Springer, Paris. https://doi.org/10.1007/978-2-287-36073-2_13

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-36073-2_13

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-36071-8

  • Online ISBN: 978-2-287-36073-2

Publish with us

Policies and ethics

Search

Navigation